Clostridium perfringens Enterotoxin Elicits Rapid and Specific Cytolysis of Breast Carcinoma Cells Mediated through Tight Junction Proteins Claudin 3 and 4-Reference-Cited by-同舟云学术

Clostridium perfringens Enterotoxin Elicits Rapid and Specific Cytolysis of Breast Carcinoma Cells Mediated through Tight Junction Proteins Claudin 3 and 4

Published:2004-05 Issue:5 Volume:164 Page:1627-1633
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Kominsky Scott L.,Vali Mustafa,Korz Dorian,Gabig Theodore G.,Weitzman Sigmund A.,Argani Pedram,Sukumar Saraswati

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference23 articles.

1. Clostridium perfringens enterotoxin;McClane;Microb Pathog,1988

2. Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops;Sarker;Mol Microbiol,1999

3. The complex interactions between Clostridium perfringens enterotoxin and epithelial tight junctions;McClane;Toxicon,2001

4. The effects of Clostridium perfringens enterotoxin on morphology, viability, and macromolecular synthesis in Vero cells;McClane;J Cell Physiol,1979

5. The relationship between cytotoxic effects and binding to mammalian culture cells of Clostridium perfringens enterotoxin;Horiguchi;FEMS Microbiol Lett,1985

Cited by 221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer;Journal of Drug Delivery Science and Technology;2024-03

2. The Expression of the Claudin Family of Proteins in Colorectal Cancer;Biomolecules;2024-02-24

3. Antibody-mediated targeting of Claudins in cancer;Frontiers in Oncology;2024-02-02

4. Spatial transcriptomic analysis drives PET imaging of tight junction protein expression in pancreatic cancer theranostics;2024-01-08

5. Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer;Therapeutic Advances in Medical Oncology;2024-01